药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201411501231319.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文索利塔-T3 No.G号输液处方资料(仅供参考)
治疗类名称
(在7.5%的糖保养液)注入电解质溶液
商标名称
索利塔-T3号输液(200毫升)
组成
这种药物包含下列组件。
在一个组件(200毫升)
氯化钠0.18克
氯化钾0.298克
L-乳酸钠0.448克
葡萄糖15.0克
一种添加剂(200毫升)中
L-乳酸(pH调节剂)适量
热量
60kcal(200毫升)
电解质浓度(毫当量/升)
Na + 35
K+ 20
氯- 35
L-乳酸- 20
禁忌
很可能加剧患者乳酸血症[乳酸血。
可能加剧的高钾血症患者的高钾血症,少尿,阿狄森氏病,严重烧伤,氮质血症,或原因。
效果或疗效
供应和维护的摄入不足或不口服,补充能量,水电解质情况
存在引起水电解质异常患者的无高钾血症肾功能衰竭,或恶化的风险。
有心脏衰竭是由钠和[水心脏衰竭患者的负担加重的危险。
水和电解质异常,则有可能会导致血液中乳酸的上升,或加剧患者严重肝损伤。
有一种可能性,引起水,电解质异常,或加重患者尿量减少尿路梗阻。
甲升高的糖尿病患者的血糖水平,它是造成水,电解质异常,或恶化的风险。
Brand Name
Solita-T3 issue infusion (200mL)
Composition
This drug contains the following components.
One component (200mL) in
Sodium chloride 0.18g
potassium chloride 0.298 g
L-lactic acid sodium 0.448g
glucose 15.0g
One additive (200mL) in
L-lactic acid (pH modifier)
appropriate amount
Amount of heat
60kcal (200mL in)
Electrolyte concentration (mEq / L)
Na + 35
K + 20
Cl - 35
L-Lactate - 20
Contraindication
Is likely to exacerbate [lactic acid blood of patients lactic acid blood disease.
Is likely to exacerbate the hyperkalemia patients with hyperkalemia, oliguria, Addison's disease, severe burns, the azotemia, or cause.
Effect or efficacy
Supply and maintenance of water-electrolyte case of inadequate or non-oral intake, supplementation of energy
I intravenous infusion adult, once 500 ~ 1000mL. The rate of administration, I and 0.5g/kg body weight or less per hour as a normal adult glucose.
Careful administration
There is a risk of causing the water-electrolyte abnormalities patients with renal failure without hyperkalemia, or exacerbation.
There is a risk of heart failure is exacerbated by the load of sodium and [Water patients with heart failure.
Water and electrolyte abnormalities, there is a possibility to cause a rise in blood lactate, or exacerbate patients with severe liver damage.
There is a possibility to cause the water, electrolyte abnormalities, or exacerbate patients urine volume is reduced by obstructive uropathy.
A rise of the blood sugar levels of diabetic patients, the risk of it being cause water, electrolyte abnormalities, or exacerbated. |